First, we analyzed the plasma concentrations of the inflammatory biomarkers (MMP-1,-2,-8, S100A8 and MPO) over the course of TB treatment within the whole cohort, regardless of HIV status or clinical outcomes. The gene discussed is MMP1; the disease is tuberculosis.